Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 16714-820

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tenofovir Disoproxil Fumarate (NDC 16714-820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tenofovir Disoproxil Fumarate 300mg 30s Count Container Label (300mg30slabel)

Each film-coated tablet contains 300 mg of Tenofovir Disoproxil Fumarate, which is equivalent to 245 mg of Tenofovir Disoproxil. This medication is used for the treatment of HIV and chronic hepatitis B. It should be stored at a temperature between 20° to 25°C (68° to 77°F) and kept in a USP Controlled Room Temperature. The tablets are manufactured by Jubilant Life Sciences Limited in Hyderabad, India and distributed by Northstar Rx LLC in Memphis, TN. Mig. Lic. No. is 22/RRIAPI2001 FIR Product of India 2048429.*

FDA Label Image

Tenofovirdisoproxilfumaratestructure (Tenofovirdisoproxilfumaratestructure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.